Evidence map›Paper›PMID 38939143›Full record

ArticleChemical science2024

Enhancing corannulene chemiluminescence, electrochemiluminescence and photoluminescence by means of an azabora-helicene to slow down its bowl inversion.

Xiaoli Qin, Lin Huang, Ziying Zhan, Peng Fu, Qing Wang, Congyang Zhang, Jianhui Huang, Zhifeng Ding

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoli QinDepartment of Chemistry, Western University London ON N6A 5B7 Canada zfding@uwo.ca.ORCID https://orcid.org/0000-0002-8872-8551
Lin HuangSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University Tianjin 300072 China jhuang@tju.edu.cn.ORCID https://orcid.org/0009-0007-9404-4467
Ziying ZhanDepartment of Chemistry, Western University London ON N6A 5B7 Canada zfding@uwo.ca.
Peng FuSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University Tianjin 300072 China jhuang@tju.edu.cn.
Qing WangSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University Tianjin 300072 China jhuang@tju.edu.cn.
Congyang ZhangDepartment of Chemistry, Western University London ON N6A 5B7 Canada zfding@uwo.ca.
Jianhui HuangSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University Tianjin 300072 China jhuang@tju.edu.cn.ORCID https://orcid.org/0000-0001-7281-663X
Zhifeng DingDepartment of Chemistry, Western University London ON N6A 5B7 Canada zfding@uwo.ca.ORCID https://orcid.org/0000-0001-9252-9320

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aromatic system extension of corannulene (Cor) is a synthetic challenge to access non-planar polyaromatic hydrocarbons (PAHs). Herein, we report the design and synthesis of azaborahelicene corannulene 1 through hybridization of an azabora[5] helical structure and subsequent luminescence studies. Significant enhancement in chemiluminescence (CL), electroluminescence (ECL) and photoluminescence (PL) is achieved compared to those of pristine Cor. Specifically, hybrid 1 shows a notable augmentation in absolute luminescence quantum efficiencies: 25-fold for CL, up to 23-fold for ECL with BPO as a coreactant, and 30-fold for PL, respectively, compared to those of pristine Cor. Intriguingly, the blue light emission observed in all three luminescence types suggests the presence of a single excited state. As revealed by variable-temperature (VT)

Identifiers

PMID38939143
PMCPMC11206500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.